Hubble Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- March 25, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $7,300,000
Company Info
- Company Description
- Hubble Therapeutics is a patient-focused biotechnology company developing a gene therapy to cure pediatric blindness, with a primary focus on developing novel gene therapy for Leber Congenital Amaurosis Type 16 (LCA16) and Snowflake Vitreoretinal Degeneration (SVD).
- Market
- Pediatric healthcare
- Location
- Hanover, New Hampshire, USA